(NAPSI)—Chronic obstructive pulmonary disease (COPD) affects approximately 16 million Americans and can make even simple ...

Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that it will release financial results for the first quarter of 2026 ...

AstraZeneca shares were up about 3.5% Friday after the company said its drug for COPD, a deadly lung disease often caused by smoking, slowed patients' symptoms in two large trials. The drug, ...

Among adults with COPD, those with vs. without cost-related nonadherence had worse symptom burden, health status and lung ...

The acquisition brings together the gold standard for continuous ambulatory cough monitoring and lung sound analysis ...

A Pocklington woman has revealed how quitting smoking 'saved her life' after a chronic lung condition that meant her lungs were as damaged as those of a 96-year-old.

A local family’s dream vacation turned into a nightmare. A Johnson City woman recently passed away after spending over two ...

The best ways to get rid of phlegm, from using nasal sprays to taking the right OTC medications. Plus, they explain what ...

Optum Arcadia, part of Optum California's medical group and physician network, has partnered with Kivo Health, an AI-enabled virtual care company, to support expanded access to at-home pulmonary ...

Extrafine single-inhaler triple therapy with BDP/FF/GB is effective for improving health-related quality of life and lung function in COPD.

Sanofi’s lunsekimig met its endpoints in asthma and CRSwNP but missed the primary endpoint in eczema.

The areas have higher rates of chronic illnesses, often linked to unhealthy lifestyles ...